Han, Weidong
Changping Laboratory,
China
2025 Rank: 75430
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2275 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75430 | 87483 |
| Total Cites | 2345 | 2392 |
| H-index | 23 | 23 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 6 | 6 |
| Number of Single+First+Last Authored Papers | 182 | 182 |
| Total Cites to Single+First+Last Authored Papers | 1354 | 1369 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1920 | 1946 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.23 |
| Self-Citation Percentage |
1.96%
|
|
Han, Weidong
General Hospital of People's Liberation Army,
China
2024 Rank: 67636
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2199 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67636 | 76124 |
| Total Cites | 2118 | 2194 |
| H-index | 23 | 24 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 10 | 10 |
| Number of Single+First+Last Authored Papers | 178 | 178 |
| Total Cites to Single+First+Last Authored Papers | 1284 | 1330 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1745 | 1776 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.24 |
| Self-Citation Percentage |
3.46%
|
|
Han, Weidong
General Hospital of People's Liberation Army,
China
2023 Rank: 66971
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2433 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66971 | 73995 |
| Total Cites | 2180 | 2253 |
| H-index | 24 | 25 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 7 | 8 |
| Number of Single+First+Last Authored Papers | 173 | 173 |
| Total Cites to Single+First+Last Authored Papers | 1463 | 1512 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1749 | 1781 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.27 |
| Self-Citation Percentage |
3.24%
|
|
Han, Weidong
General Hospital of People's Liberation Army,
China
2022 Rank: 64530
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2470 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64530 | 74523 |
| Total Cites | 1814 | 1886 |
| H-index | 22 | 22 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 14 | 14 |
| Number of Single+First+Last Authored Papers | 166 | 166 |
| Total Cites to Single+First+Last Authored Papers | 1268 | 1318 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1467 | 1503 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.25 |
| Self-Citation Percentage |
3.82%
|
|
Han, Weidong
General Hospital of People's Liberation Army,
China
2021 Rank: 73270
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2671 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73270 | 80530 |
| Total Cites | 2296 | 2413 |
| H-index | 26 | 27 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 25 | 25 |
| Number of Single+First+Last Authored Papers | 156 | 156 |
| Total Cites to Single+First+Last Authored Papers | 1689 | 1771 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1873 | 1927 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.25 |
| Self-Citation Percentage |
4.85%
|
|
Han, Weidong
General Hospital of People's Liberation Army,
China
2020 Rank: 94331
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3258 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94331 | 98725 |
| Total Cites | 1312 | 1412 |
| H-index | 18 | 21 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 16 | 16 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 1038 | 1112 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1084 | 1116 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.27 |
| Self-Citation Percentage |
7.08%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.